JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan International Research Enhanced Equity ETF
JIRE
|
+$4.16B |
| 2 |
Microsoft
MSFT
|
+$2.29B |
| 3 |
Amazon
AMZN
|
+$2B |
| 4 |
UnitedHealth
UNH
|
+$1.76B |
| 5 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$1.42B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$4.61B |
| 2 |
Vanguard Short-Term Bond ETF
BSV
|
+$1.58B |
| 3 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$689M |
| 4 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$659M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$647M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.03% |
| 2 | Healthcare | 12.52% |
| 3 | Financials | 10.5% |
| 4 | Consumer Discretionary | 7.88% |
| 5 | Industrials | 7.32% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4676
CALL
Heron Therapeutics
HRTX
$63.5M
| $279K | ﹤0.01% |
+100,000
| New | +$402K |
|
|
CRGE
4677
DELISTED
Charge Enterprises, Inc. Common Stock
CRGE
| $276K | ﹤0.01% |
+57,817
| New | +$298K |
|
4678
CALL
Kroger
KR
$34.3B
| $275K | ﹤0.01% |
5,800
-163,500
| -97% | -$8.71M |
|
4679
National Presto Industries
NPK
$998M
| $274K | ﹤0.01% |
4,178
-41,923
| -91% | -$2.98M |
|
4680
CALL
Madison Square Garden
MSGS
$9.97B
| $272K | ﹤0.01% |
+1,800
| New | +$292K |
|
|
ORC
4681
Orchid Island Capital
ORC
$1.32B
| $272K | ﹤0.01% |
19,118
-23,301
| -55% | -$346K |
|
4682
Sportradar
SRAD
$3.84B
| $272K | ﹤0.01% |
34,417
-295,630
| -90% | -$3.23M |
|
4683
Ranpak Holdings
PACK
$464M
| $271K | ﹤0.01% |
38,656
+9,556
| +33% | +$123K |
|
|
PNT
4684
DELISTED
POINT Biopharma Global Inc. Common Stock
PNT
| $271K | ﹤0.01% |
39,776
+19,616
| +97% | +$150K |
|
4685
HCI Group
HCI
$2.28B
| $270K | ﹤0.01% |
3,977
+1,151
| +41% | +$76K |
|
4686
Hyster-Yale Materials Handling
HY
$614M
| $270K | ﹤0.01% |
8,397
-2,178
| -21% | -$74.1K |
|
4687
TETRA Technologies
TTI
$1.29B
| $270K | ﹤0.01% |
66,556
-65,741
| -50% | -$290K |
|
|
PETQ
4688
DELISTED
PetIQ, Inc. Class A Common Stock
PETQ
| $270K | ﹤0.01% |
16,050
+3,195
| +25% | +$58.6K |
|
4689
PUT
Western Digital
WDC
$168B
| $269K | ﹤0.01% |
7,938
| – | – |
|
4690
Bank of Marin Bancorp
BMRC
$462M
| $268K | ﹤0.01% |
8,447
+1,040
| +14% | +$33.6K |
|
4691
Invesco DB Oil Fund
DBO
$387M
| $268K | ﹤0.01% |
14,674
-5,187
| -26% | -$97.2K |
|
4692
CALL
FMC
FMC
$1.28B
| $268K | ﹤0.01% |
2,500
| – | – |
|
4693
SelectQuote
SLQT
$126M
| $268K | ﹤0.01% |
108,180
+8,880
| +9% | +$22.8K |
|
4694
Sumitomo Mitsui Financial
SMFG
$167B
| $268K | ﹤0.01% |
45,511
-54,047
| -54% | -$326K |
|
4695
Nature's Sunshine
NATR
$273M
| $267K | ﹤0.01% |
24,953
-3,413
| -12% | -$47.4K |
|
|
NVO
4696
CALL
Novo Nordisk
NVO
$205B
| $267K | ﹤0.01% |
+4,800
| New | +$266K |
|
4697
Zegna
ZGN
$3.76B
| $267K | ﹤0.01% |
+25,290
| New | +$259K |
|
4698
Vanguard Russell 2000 Value ETF
VTWV
$1.38B
| $265K | ﹤0.01% |
2,228
-596
| -21% | -$77.8K |
|
4699
CALL
Campbell Soup
CPB
$6.74B
| $264K | ﹤0.01% |
5,500
-38,100
| -87% | -$1.79M |
|
4700
iShares Core US REIT ETF
USRT
$4.63B
| $264K | ﹤0.01% |
4,943
+97
| +2% | +$5.7K |
|
Similar funds
JP Morgan Chase's Q2 2022 Portfolio in Review
As of Q2 2022, JP Morgan Chase held 7,270 positions worth $718B, down 14% from $830B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
JP Morgan Chase's Q2 2022 filing shows 568 new, 2,561 increased, 2,729 reduced and 610 closed positions. Its largest new stake was JPMorgan International Research Enhanced Equity ETF: 85,906,762 shares worth $4.15B. The largest sale was JPMorgan BetaBuilders Europe ETF, an estimated $4.61B.
By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 16% a quarter earlier, followed by Healthcare and Financials.
- JP Morgan Chase's largest Q2 2022 buy was JPMorgan International Research Enhanced Equity ETF: 85,906,762 shares worth $4.15B.
- JP Morgan Chase added most to Microsoft in Q2 2022, an estimated $2.29B increase.
- JP Morgan Chase's biggest Q2 2022 reduction was JPMorgan BetaBuilders Europe ETF, cutting an estimated $4.61B.
- JP Morgan Chase fully exited Cerner Corp in Q2 2022, selling an estimated $608M.
- JP Morgan Chase's ten largest holdings make up 18% of its $718B portfolio in Q2 2022.
- JP Morgan Chase opened 568 new positions and closed 610 in Q2 2022.
- JP Morgan Chase's portfolio value fell 14% quarter-over-quarter to $718B.
Based on JP Morgan Chase's 13F filing for Q2 2022, filed 11 Aug 2022.